Many thousands of men around the world are missing out on a life-extending prostate cancer drug that’s available free in some countries.
Although not a cure, Abiraterone can help stop prostate cancer spreading to other parts of the body.
Recently one drug trial showed that Abiraterone could benefit a larger group of men with earlier stage tumours that hadn’t yet started to spread.
The medicine works by lowering testosterone production in the body which can fuel some cancer cell growth. The study showed it could halve the risk of the cancer spreading and significantly reduce the chance of death six years on from diagnosis in that group.
However differences in national health care systems mean that while in some countries men are being given the treatment, many others are missing out.
The UK illustrates this health inequality. In England and Northern Ireland, the state national health service will only provide it for men with very advanced disease, when other treatments have failed. However in the neighbouring UK nations of Scotland and Wales the drug is more widely available.
Fiona Bruce presents BBC News at Six reporting by health editor Hugh Pym.
Please subscribe here: http://bit.ly/1rbfUog
#BBCNews
MILANO (ITALPRESS) – L’Italia viene sconfitta 3-1 dalla Francia al Meazza nell’ultima giornata della fase a gironi della Nations League…
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
High inside the Arctic circle, the archipelago of Svalbard is one of the fastest warming places on Earth. Yet for…
TORINO (ITALPRESS) – Jannik Sinner profeta in patria. Il tennista azzurro, 23enne, numero uno del mondo, ha vinto le Atp…
MILANO (ITALPRESS) – “Abbiamo votato tutti quanti per l’autonomia differenziata, siamo favorevoli. Noi di Forza Italia abbiamo sempre detto che…
PALERMO (ITALPRESS) – L’Open day itinerante della prevenzione torna a Palermo per una giornata all’insegna della prevenzione nel quartiere Danisinni.…